1666.9000 56.40 (3.50%)
NSE Apr 08, 2026 12:04 PM
Volume: 109.9K
 

1666.90
3.50%
ICICI Securities Limited
The Q3FY21 operational performance was mostly in line with our expectations whereas profitability was below due to lower than expected other income. Revenues grew 20.2% YoY to | 274 crore. EBITDA margins improved 89 bps YoY to 30.6% due to higher gross margins, lower other expenses partly offset by higher staff costs likely due to acquired subsidiaries. Hence, EBITDA grew 23.9% YoY to | 84 crore. However, PAT...
Caplin Point Laboratories Ltd. is trading below its 50 day SMA of 1694.4
More from Caplin Point Laboratories Ltd.
Recommended